ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1: initial diagnosis, monitoring of known inflammatory bowel disease, detection of complications - Summary - MDSpire

ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1: initial diagnosis, monitoring of known inflammatory bowel disease, detection of complications

  • By

  • Torsten Kucharzik

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Stuart Taylor

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Mariangela Allocca

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Johan Burisch

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Pierre Ellul

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Marietta Iacucci

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Christian Maaser

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Pamela Baldin

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Gauraang Bhatnagar

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Shomron Ben-Horin

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Dominik Bettenworth

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Mallory Chavannes

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Ann Driessen

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Emma Flanagan

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Frederica Furfaro

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Giovanni Maconi

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Konstaninos Karmiris

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Amelia Kellar

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Isabelle De Kock

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Konstantinos Katsanos

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Uri Kopylov

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Cathy Lu

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Olga Maria Nardone

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Nurulamin M Noor

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Kerri Novak

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Paula Borralho Nunes

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Patrick van Rheenen

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Jordi Rimola

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Francesca Rosini

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • David Rubin

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Martina Scharitzer

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Jaap Stoker

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Mathieu Uzzan

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Stephan Vavricka

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Bram Verstockt

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Rune Wilkens

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Nina Zidar

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Alessandra Zilli

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Henit Yanai

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • Roger Feakins

  • the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • July 31, 2025

  • 0 min

Share

Objective:

To provide comprehensive guidance on the diagnosis and monitoring of patients with inflammatory bowel disease (IBD), including initial diagnosis, complication detection, and the use of monitoring tools in specific clinical scenarios.

Key Findings:
  • Colonoscopy remains the cornerstone diagnostic tool for IBD, allowing direct examination and biopsy.
  • The guidelines provide recommendations for monitoring tools and diagnostics in specific situations such as pregnancy and cancer surveillance, emphasizing tailored approaches.
  • Evidence gaps were identified to stimulate future research in IBD management, highlighting areas needing further investigation.
Interpretation:

The guidelines aim to standardize and improve the diagnostic and monitoring processes for IBD, enhancing patient care through evidence-based recommendations.

Limitations:
  • The guidelines are based on studies published in English, which may limit the scope of evidence considered and affect the generalizability of recommendations.
  • Some recommendations may not cover all specific clinical scenarios due to evidence gaps, necessitating clinical judgment.
Conclusion:

These updated guidelines serve as a vital resource for healthcare professionals involved in the management of IBD, ensuring that patients receive optimal diagnostic and monitoring care.

Original Source(s)

ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1: initial diagnosis, monitoring of known inflammatory bowel disease, detection of complications

  • by Torsten Kucharzik, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Stuart Taylor, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Mariangela Allocca, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Johan Burisch, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Pierre Ellul, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Marietta Iacucci, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Christian Maaser, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Pamela Baldin, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Gauraang Bhatnagar, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Shomron Ben-Horin, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Dominik Bettenworth, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Mallory Chavannes, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Ann Driessen, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Emma Flanagan, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Frederica Furfaro, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Giovanni Maconi, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Konstaninos Karmiris, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Amelia Kellar, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Isabelle De Kock, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Konstantinos Katsanos, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Uri Kopylov, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Cathy Lu, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Olga Maria Nardone, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Nurulamin M Noor, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Kerri Novak, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Paula Borralho Nunes, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Patrick van Rheenen, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Jordi Rimola, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Francesca Rosini, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), David Rubin, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Martina Scharitzer, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Jaap Stoker, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Mathieu Uzzan, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Stephan Vavricka, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Bram Verstockt, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Rune Wilkens, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Nina Zidar, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Alessandra Zilli, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Henit Yanai, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Roger Feakins, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)

  • July 31, 2025

Related Content

Metabolic and Structural Alterations Linked to Mice's Vulnerability to Primary Echinostoma caproni Infections

Sex-related peripheral immune profile in ulcerative colitis: links to fatigue

Editorial: Volume II of the Community Series on Gut Microbiota and Immune Interactions in Intestinal Disorders